𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cerebral diaschisis in patients with malignant glioma

✍ Scribed by Jack M. Rozental; Ross L. Levine; Robert J. Nickles; Jeffrey A. Dobkin; Joan M. Hanson


Book ID
104652453
Publisher
Springer US
Year
1990
Tongue
English
Weight
738 KB
Volume
8
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

✦ Synopsis


A positron emission tomography study using [18F]-fluorodeoxyglucose was undertaken to identify and quantitate whether diaschisis occurred in cerebral cortex, basal ganglia, or thalamus, as well as in cerebellar cortex and dentate nuclei in patients with malignant glioma. The relationship between diaschisis in these cerebral structures and clinically significant hemiparesis in patients was analysed. A 30% decrease in the regional metabolic rate for glucose in the cerebellar hemisphere contralateral to the tumor, and ipsilateral to the motor deficit, was identified and was statistically significant (p > 0.001). Decreased metabolism in the cerebellar hemisphere contralateral to the tumor was not seen in patients without hemiparesis. Parietal lobes affected by tumor had a larger decrease in metabolism than did frontal lobes with tumor (p > 0.01). The overall metabolism of the unaffected cerebellar hemisphere, relative to the peak metabolic activity of the brain, was not depressed in patients with tumor. In addition, the activity of subcortical nuclei was relatively unaffected by adjacent tumor or motor deficit.


πŸ“œ SIMILAR VOLUMES


High-grade gliomas in patients with prio
✍ Fernando C. Maluf; Lisa M. DeAngelis; Jeffrey J. Raizer; Lauren E. Abrey πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 301 KB

## Abstract ## BACKGROUND The current study was conducted to characterize the impact of a prior malignancy on the diagnosis, treatment, and outcome of high‐grade glioma. ## METHODS A retrospective study of 21 patients with a histologic diagnosis of glioblastoma multiforme (GBM), anaplastic astro

Intravenous BCNU and AZQ in patients wit
✍ W.K.A. Yung; M.I. Harris; J.M. Bruner; L.G. Feun πŸ“‚ Article πŸ“… 1989 πŸ› Springer US 🌐 English βš– 293 KB

Twenty-four patients with recurrent malignant glioma were treated with intravenous BCNU (80 mg/m2/ day x 3 days) alternating with AZQ (8 mg/mZ/day x 5 days) every 6--8 weeks. Twenty patients received two or more courses of chemotherapy, ten anaplastic astrocytomas (AA), eight glioblastomas (GBM), an